Survival analysis after hip fracture: higher mortality than the general population and delayed surgery increases the risk at any time.


Journal

Hip international : the journal of clinical and experimental research on hip pathology and therapy
ISSN: 1724-6067
Titre abrégé: Hip Int
Pays: United States
ID NLM: 9200413

Informations de publication

Date de publication:
Sep 2020
Historique:
entrez: 10 9 2020
pubmed: 11 9 2020
medline: 23 2 2021
Statut: ppublish

Résumé

To estimate survival curves in patients with hip fracture according to gender, age, type of fracture, and waiting time for surgery and to compare them with the life expectancy of the general population. The study hypothesis is that survival after hip fractures is significantly lower than in the general population, especially in cases that underwent delayed surgery, regardless of age and gender. A survival analysis study was designed and approved by our institutional ethics review board. All patients who were coded with a diagnosis of hip fracture from 2002 to 2018 were included in the study. A total of 1176 patients were included, and the median age was 81 years (18-105 years). Kaplan-Meier curves and log-rank tests were performed to compare survival curves between those who underwent surgery on time and those with surgical delays. An exponential multivariate regression model was estimated, and a hazard ratio (HR) was reported for age, gender, and wait time for surgery. A significance of 5% was used, and a confidence interval level of 95% was reported. The Kaplan-Meier curves for delayed surgery (log-rank, The 2 significant findings of this study are that hip fracture patients over 40 years old have a higher risk of dying at any time compared to the general population and that the waiting time for surgery (a modifiable factor) decreases survival rates at any time.

Identifiants

pubmed: 32907421
doi: 10.1177/1120700020938029
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-58

Auteurs

Maximiliano Barahona (M)

Orthopaedic Department, University of Chile Clinical Hospital, Santiago, Chile.

Cristian Barrientos (C)

Orthopaedic Department, University of Chile Clinical Hospital, Santiago, Chile.

Gabriel Cavada (G)

Epidemiology Department, University of Chile, Santiago, Chile.

Julián Brañes (J)

Orthopaedic Department, University of Chile Clinical Hospital, Santiago, Chile.

Álvaro Martinez (Á)

Orthopaedic Department, San José Hospital, Santiago, Chile.

Jaime Catalan (J)

Orthopaedic Department, University of Chile Clinical Hospital, Santiago, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH